586 related articles for article (PubMed ID: 35301281)
1. Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases.
Risso V; Lafont E; Le Gallo M
Cell Death Dis; 2022 Mar; 13(3):248. PubMed ID: 35301281
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models.
Quijano-Rubio C; Silginer M; Weller M
J Neurooncol; 2022 Nov; 160(2):299-310. PubMed ID: 36355258
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of cells with combined apoptosis and proliferation markers in thyroid tissue specimens from patients with cancer, adenoma, and autoimmune diseases.
Kazakov SP; Zabotina TN; Korotkova OV; Dzabarov AK; Kazantseva IA
Bull Exp Biol Med; 2011 Feb; 150(4):453-8. PubMed ID: 22268042
[TBL] [Abstract][Full Text] [Related]
4. CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways.
Haymour L; Jean M; Smulski C; Legembre P
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189004. PubMed ID: 37865305
[TBL] [Abstract][Full Text] [Related]
5. CD95 Stimulation with CD95L and DISC Analysis.
Le Gallo M; Legembre P
Methods Mol Biol; 2017; 1557():11-18. PubMed ID: 28078578
[TBL] [Abstract][Full Text] [Related]
6. Nonapoptotic functions of Fas/CD95 in the immune response.
Guégan JP; Legembre P
FEBS J; 2018 Mar; 285(5):809-827. PubMed ID: 29032605
[TBL] [Abstract][Full Text] [Related]
7. The dual role of the CD95 and CD95L signaling pathway in glioblastoma.
Zhang Y; Jin T; Dou Z; Wei B; Zhang B; Sun C
Front Immunol; 2022; 13():1029737. PubMed ID: 36505426
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic overexpression of CD95L in esophageal adenocarcinoma cells overcomes resistance to CD95-mediated apoptosis.
Watson GA; Naran S; Zhang X; Stang MT; Queiroz de Oliveira PE; Hughes SJ
Neoplasia; 2011 Mar; 13(3):198-205. PubMed ID: 21390183
[TBL] [Abstract][Full Text] [Related]
9. CD95 signaling in cancer treatment.
De la Rosa AJ; Gomez MA; Morales S; Padillo FJ; Muntane J
Curr Pharm Des; 2014; 20(17):2809-18. PubMed ID: 23944368
[TBL] [Abstract][Full Text] [Related]
10. Amplification of CD95 activation by caspase 8-induced endosomal acidification in rat hepatocytes.
Reinehr R; Sommerfeld A; Keitel V; Grether-Beck S; Haüssinger D
J Biol Chem; 2008 Jan; 283(4):2211-22. PubMed ID: 18045865
[TBL] [Abstract][Full Text] [Related]
11. CD95/Fas ligand induced toxicity.
Haluck-Kangas A; Peter ME
Biochem Soc Trans; 2023 Feb; 51(1):21-29. PubMed ID: 36629505
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR.
Pinti M; Nasi M; Moretti L; Mussini C; Petrusca D; Esposito R; Cossarizza A
Ann N Y Acad Sci; 2000; 926():46-51. PubMed ID: 11193040
[TBL] [Abstract][Full Text] [Related]
13. Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.
Lang I; Fick A; Schäfer V; Giner T; Siegmund D; Wajant H
J Biol Chem; 2012 Jul; 287(28):24026-42. PubMed ID: 22645131
[TBL] [Abstract][Full Text] [Related]
14. Role of metalloproteases in the CD95 signaling pathways.
Devel L; Guedeney N; Bregant S; Chowdhury A; Jean M; Legembre P
Front Immunol; 2022; 13():1074099. PubMed ID: 36544756
[TBL] [Abstract][Full Text] [Related]
15. Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand.
Ng CS; Lo ST; Chan JK
Hum Pathol; 1999 Jan; 30(1):48-53. PubMed ID: 9923926
[TBL] [Abstract][Full Text] [Related]
16. DICE: A novel tumor surveillance mechanism-a new therapy for cancer?
Peter ME
Cell Cycle; 2014; 13(9):1373-8. PubMed ID: 24690893
[TBL] [Abstract][Full Text] [Related]
17. CD95 ligand: lethal weapon against malignant glioma?
Weller M; Kleihues P; Dichgans J; Ohgaki H
Brain Pathol; 1998 Apr; 8(2):285-93. PubMed ID: 9546287
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation and CD95: a FAScinating switch.
Sancho-Martinez I; Martin-Villalba A
Cell Cycle; 2009 Mar; 8(6):838-42. PubMed ID: 19221505
[TBL] [Abstract][Full Text] [Related]
19. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells.
Fulda S; Strauss G; Meyer E; Debatin KM
Blood; 2000 Jan; 95(1):301-8. PubMed ID: 10607716
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]